Dupilumab - Standard Dose Clinical Trials
3 recruitingDrug
Phase 41
Showing 1–3 of 3 trials
Recruiting
Phase 4
Dupilumab De-escalation in Pediatric Atopic Dermatitis
Atopic Dermatitis
Johns Hopkins University30 enrolled1 locationNCT06116526
Recruiting
Dupilumab Therapy for EGIDs
Eosinophilic Gastrointestinal Disorders (EGIDs)
Children's Hospital of Fudan University20 enrolled1 locationNCT07257835
Recruiting
Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
Smell LossChronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
Northwestern University30 enrolled1 locationNCT06892704